1. INITIAL RESULTS OF THE RE-VERSE AD TRIAL: IDARUCIZUMAB REVERSES THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY OR INTERVENTIONS. Issue 12 (23rd November 2015) Authors: Pollack, C; Eikelboom, J; Weitz, J; Reilly, P; Glund, S; Dubiel, R; Kreuzer, J; Stangier, J; Wang, B; Gagg, J; Verhamme, P; Bernstein, R; Huisman, M; Hylek, E; Kamphuisen, P; Levy, J; Selke, F; Steiner, T; Kam, C Journal: Emergency medicine journal Issue: Volume 32:Issue 12(2015) Page Start: 979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗